Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter (213)Bi

[Image: see text] Here, we propose tailored lipid liquid-crystalline carriers (cubosomes), which incorporate an anticancer drug (doxorubicin) and complexed short-lived α-emitter (bismuth-213), as a strategy to obtain more effective action toward the cancer cells. Cubosomes were formulated with doxor...

Descripción completa

Detalles Bibliográficos
Autores principales: Cytryniak, Adrianna, Żelechowska-Matysiak, Kinga, Nazaruk, Ewa, Bilewicz, Renata, Walczak, Rafał, Majka, Emilia, Mames, Adam, Bruchertseifer, Frank, Morgenstern, Alfred, Bilewicz, Aleksander, Majkowska-Pilip, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346610/
https://www.ncbi.nlm.nih.gov/pubmed/35849547
http://dx.doi.org/10.1021/acs.molpharmaceut.2c00182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346610/
https://www.ncbi.nlm.nih.gov/pubmed/35849547
http://dx.doi.org/10.1021/acs.molpharmaceut.2c00182

Ejemplares similares